Pharmacological management of nonalcoholic fatty liver disease: Limitations, challenges and new therapeutic opportunities Eleni A. Karavia, Kyriakos E. Kypreos
Non-alcoholic fatty liver disease in HIV – infected patients without viral hepatitis What can we do about their cardiovascular risk G. Sfikas, Chr. Boutari, K. Tassios, K. Kaitanidis, E. Mitsiou, V.G. Athyros
Non-alcoholic fatty liver disease in HIV-infected patients without viral hepatitis. What can we do about their cardiovascular risk? Georgios Sfikas, Chrysoula Boutari, Konstandinos Tassios, Konstantinos Kaitanidis, Eydoxia Mitsiou, Vasilios G. Athyros